Escapelle

Escapelle is included into group of the post-coital contraceptives intended for oral administration.

Pharmacological action

Escapelle belongs to post-coital contraceptives with anti-oestrogenic and gestagenny actions. At use in the dosage described in the instruction to Escapelle, drug promotes suppression of an ovulation and fertilization even if sexual intercourse happened when probability of conception the highest (during a preovulyatorny phase of a cycle of periods). Also reception of means interferes with implantation of an oospore due to ability to slow down proliferation of an endometria. However it is necessary to consider that at the taken place implantation efficiency of drug considerably decreases, up to a zero mark.

Drug, in case of observance of the recommended dosage, does not influence processes of fatty and carbohydrate exchanges and fibrillation.

Escapelle is recommended to use within the first 3 days (72 h) after the unprotected sexual intercourse. Efficiency of effect of Escapelle considerably decreases after time (so, it reaches 95% in the first 24 h, on second day makes 85%, during the period between 48 and 72 h it is equal to about 58%).

Form of production of Escapelle

The only form of production of Escapelle are tablets which color is close to white. Tablets have the round form, flat, on one of the parties the facet and an engraving of "GOO" is located. One pack contains 1 tablet packed into the blister.

Indications to Escapelle use

According to the instruction Escapelle should be accepted as the emergency means of post-coital contraception: after use of an unreliable method of contraception or after sexual intercourse without use of contraceptives.

Contraindications

Numerous medical reviews of Escapelle do not recommend to accept drug in the following cases:

• At a heavy renal failure;
• If age of the patient less than 16 years;
• At pregnancy;
• At a lactose intolerance, deficit of lactase or malabsorption of galactose/glucose;
• At hypersensitivity to Escapelle components.

With care use for patients with the diagnosed diseases of kidneys, with jaundice (including postponed earlier) is possible, and also at a disease Krone and during feeding by a breast.

Application instruction of Escapelle

Escapelle needs to be accepted orally on one tablet (1,5 mg) as soon as possible after the unprotected sexual intercourse, however it is strict within 72 h. It must be kept in mind that efficiency of Escapelle of subjects is lower, than more time passed from the moment of the unprotected sexual intercourse. If use of drug provoked vomiting (during 3 h from the moment of reception), it is necessary to take medicine repeatedly in the same dose (1,5 mg).

Drug is admissible to use in any phase of a menstrual cycle. If the cycle is irregular, first of all it is necessary to exclude pregnancy existence.

After use of Escapelle and up to time of approach of the following periods it is necessary to apply barrier kontratseptichesky means (condom). Administration of drug during one cycle of periods as the probability of increase in frequency of bleedings or bloody allocations of acyclic character is high is not recommended.

Side effects of Escapelle

In certain cases use of Escapelle is capable to provoke emergence of undesirable reactions which treat:

• Allergy in the form of a face edema, small tortoiseshells, an itch and rash;
• Vomiting, diarrhea, nausea;
• Dizziness, fatigue, headache;
• Pains in the lower part of a stomach, a periods delay (for the term of no more than a week), acyclic bleedings, morbidity of mammary glands.

Similar side reactions does not demand medicamentous therapy.

Special instructions

According to medical reviews of Escapelle, drug is used only in case of an emergency contraception. Medicine cannot serve as a substitute of regular contraception and is not recommended to use more often than once during one cycle of periods.

Effect of Escapelle is not directed to protection against diseases, sexually transmitted.

Storage conditions

Escapelle is stored up to 5 years in case of observance of storage conditions: out of reach of children, in the dark place, where to temperature not above 25 °C.